Foundation Medicine Appoints Chadi Nabhan, M.D., MBA, as Chief Medical Officer

Share

facebook-icon linkedin-icon twitter pinterest

Chadi Nabhan

Foundation Medicine Appoints Chadi Nabhan, M.D., MBA, as Chief Medical Officer
Foundation Medicine, Inc., a global, patient-focused precision medicine company, has appointed Chadi Nabhan, M.D., MBA, as Chief Medical Officer.

Foundation Medicine, Inc., a global, patient-focused precision medicine company, has appointed Chadi Nabhan, M.D., MBA, as Chief Medical Officer.

In this role, Dr. Nabhan will lead the company's global medical affairs and clinical development, supporting the advancement of precision oncology and the development of innovative approaches to cancer care.

Dr. Nabhan brings more than 20 years of leadership experience spanning clinical oncology, academic research, genomics and healthcare technology. His background includes senior executive positions at several healthcare and life sciences organisations, with a focus on advancing cancer research and improving patient outcomes.

Most recently, he served as Chief Medical Officer at Ryght, where he championed the application of artificial intelligence (AI) to optimise clinical trials and research site selection. Before that, he was Senior Vice President and Chairman of the Precision Oncology Alliance at Caris Life Sciences. During his tenure, he helped expand the organisation's collaborative oncology research network to strengthen precision cancer care Earlier in his career, Dr. Nabhan held the positions of Executive Vice President and Chief Medical Officer at Aptitude Health, and Vice President and Chief Medical Officer at Cardinal Health Specialty Solutions.

Alongside his industry leadership, Dr. Nabhan has an extensive academic and clinical background. He served as Associate Professor of Medicine and Medical Director of the Clinical Outpatient Cancer Center at the University of Chicago Medicine and held leadership positions at Advocate Lutheran General Hospital.

A prolific contributor to medical research, Dr. Nabhan has authored more than 400 peer-reviewed manuscripts, abstracts and book chapters. His appointment is expected to strengthen Foundation Medicine's medical and clinical leadership as it continues to advance precision oncology for patients across all stages of cancer.